🇺🇸 FDA
Pipeline program

Quadrivalent Influenza Vaccine (Split Virion), inactivated

PRO-QINF-4003

Approved mab completed

Quick answer

Quadrivalent Influenza Vaccine (Split Virion), inactivated for Seasonal Influenza is a Approved program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Seasonal Influenza
Phase
Approved
Modality
mab
Status
completed

Clinical trials